Quantification of neck and trunk tilt during standing in Parkinson’s disease
Objective: We analyzed the motion of PD patients using the Markerless Motion Capture System (MLS) and examined the quantification of motion and its usefulness. Background:…Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson’s disease
Objective: The present study aimed to determine whether a different peripheral immune profile and neutrophil-to-lymphocyte ratio were present in Parkinson’s disease (PD) patients compared with…Gut microbiota in patients with Parkinson’s disease (PD) predicts disease progression better than clinical features
Objective: To compare machine-learning models to predict the progression of PD using gut microbiota and clinical features. Background: A total of 21 studies including ours…Subclinical inflammation and Parkinson’s disease
Objective: To investigate subclinical inflammation in individuals with early drug-naive Parkinson’s disease (PD). Background: Neutrophil-to-lymphocyte ratio (NLR) is used as a marker of subclinical inflammation.…Motor Function Test Protocol for Parkinsonian Triad in Rodent Model of Parkinson’s Disease
Objective: To review motor deficits protocols and create a set of behavioural protocols that critically address the parkinsonian triad's quantification in Parkinson's disease models. Background:…Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson’s disease and progressive supranuclear palsy
Objective: We aimed to evaluate cerebrospinal fluid (CSF) levels of oxidative stress (OS) and antioxidant potential using diacron-reactive oxygen metabolites (d-ROMs) and biological antioxidant potential…Daily fluctuations of plasma ghrelin level in patients with different motor subtypes of Parkinson`s disease
Objective: The objective of this study is to compare evening and morning plasma ghrelin level in patients with different motor subtypes of Parkinson`s disease (PD).…Piecing Together the Gut Microbiome in Parkinson’s Disease: A Meta-Analysis
Objective: To investigate fecal microbiome changes in Parkinson’s disease (PD) vs. controls by meta-analysis of 16S rRNA gene sequences from different studies. Background: The role…Effects of Angiotensin Type 1 Receptor Antagonists on Parkinson’s Disease Progression: an exploratory study in the PPMI database
Objective: The objective of this study is to analyze the effect of exposure to AT1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) on the clinical…Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson’s disease
Objective: The objective of this study was to assess if soluble urokinase-type plasminogen activator receptor (SuPAR) is elevated in patients with Parkinson's disease (PD). Background:…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.